Page values for "Fluticasone"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Fluticasone
brand	`String`	Flonase (intranasal, OTC); Flovent (inhaled, asthma); Cutivate (topical)
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Corticosteroids\|Corticosteroid]] • [[:Category:Glucocorticoids\|Glucocorticoid]] • [[:Category:Inhaled_corticosteroids\|Inhaled corticosteroid (ICS)]]
mechanism	`String`
uses	`String`	'"`UNIQ--vote-000001D9-QINU`"', '"`UNIQ--vote-000001DA-QINU`"', '"`UNIQ--vote-000001DB-QINU`"', '"`UNIQ--vote-000001DC-QINU`"'
starting_dose	`String`	Inhaled (Flovent HFA) 88 mcg BID; intranasal (Flonase) 2 sprays/nostril daily; topical (Cutivate) 0.05% cream BID
preparations	`String`	Inhaled MDI 44/110/220 mcg per actuation; DPI (Diskus) 50/100/250 mcg; nasal spray 50 mcg/actuation; cream/ointment 0.005%, 0.05%
fda_max	`String`	ICS 880 mcg/d (asthma); intranasal 200 mcg/d
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Inhaled • intranasal • topical
onset	`String`	Inhaled: bronchial effect 1-2 weeks; nasal: symptom relief 12-24 hours; topical: hours
duration	`String`	12-24 hours per dose
halflife	`String`	~7.8 hours (fluticasone propionate, inhaled systemic exposure)'"`UNIQ--ref-000001DD-QINU`"'
bioavailability	`String`	<1% oral (extensive first-pass via CYP3A4); ~30% inhaled lung deposition'"`UNIQ--ref-000001DE-QINU`"'
pregnancy	`String`	Inhaled and intranasal generally considered safe; widely used in asthma in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	OTC (intranasal Flonase) and [[USLegal:Prescription only\|Rx-only]] (inhaled, topical) in US